Shortage Avoided

ARIXTRA

ASPEN PHARMACARE CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ARIXTRA in Canada?

Not currently. The most recent shortage report for ARIXTRA 2.5MG is marked resolved (last updated December 22, 2021).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength2.5MG

Last updated2021-12-22

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02245531

Strength

2.5MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

FONDAPARINUX SODIUM

Tier

Unrated

Last Updated

2021-12-22

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

ARIXTRA has 2 shortage/discontinuation reports on file — this is one of them.

2021-12-22

Shortage Avoided

Delay in shipping of the drug.

Other Products from ASPEN PHARMACARE CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

2MG · DIN 00004715

DIN 02087286

7.5MG · DIN 02258056

2MG · DIN 02493055

10MG · DIN 02018950

300MCG · DIN 02213230